Cargando…
A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal
Typhoid remains one of the major serious health concerns for children in developing countries. With extremely drug-resistant cases emerging, preventative measures like sanitation and vaccination, including typhoid conjugate vaccines (TCV) remain the mainstay in its prevention and control. Different...
Autores principales: | Chaudhary, Shipra, Shah, Gauri Shankar, Bhatta, Nisha Keshary, Poudel, Prakash, Rai, Basant, Uranw, Surendra, Tripathi, Prashant Mani, Khanal, Basudha, Ghimire, Anup, Rai, Nikita, Gupta, Birendra Prasad, Vemula, Sridhar, Wartel, T. Anh, Sahastrabuddhe, Sushant, Saluja, Tarun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142305/ https://www.ncbi.nlm.nih.gov/pubmed/37128723 http://dx.doi.org/10.1080/21645515.2023.2203634 |
Ejemplares similares
-
A multi-centre, post-marketing surveillance study of Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar TCV®) in India
por: Reddy, Raghu, et al.
Publicado: (2021) -
Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice
por: Komla, Essie, et al.
Publicado: (2021) -
THE IMMUNOCHEMISTRY OF TOXINS AND TOXOIDS : VI. THE CRYSTALLIZATION AND CHARACTERIZATION OF TETANAL TOXIN
por: Pillemer, Louis, et al.
Publicado: (1948) -
Immunization with Tetanus Toxoid: The Recall Response
por: Strenge, Henry B.
Publicado: (1940) -
Safety, immunogenicity and non-interference of concomitant Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV®) and measles or measles-mumps-rubella vaccines in 8–9 months-old Indian children
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2022)